Amphastar Pharma (AMPH) Tops Q4 EPS by 2c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/24/2026

1. DECK
2. RNG
3. WDC
4. BYD
5. SPOT
6. WCN
7. BMY
8. TSCO
9. BE
10. SPY

Go back to Amphastar Pharma (AMPH) Tops Q4 EPS by 2c

Amphastar Pharmaceuticals Reports Financial Results for the Three Months and Full Year Ended December 31, 2018

March 12, 2019 4:05 PM EDT

Reports Net Revenues of $89.7 Million for the Three Months Ended December 31, 2018

RANCHO CUCAMONGA, Calif., March 12, 2019 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) (Amphastar or the Company) today reported results for the three months and full year ended December 31, 2018.

Fourth Quarter Highlights

Net revenues of $89.7 million for the fourth quarter, up 48% from the quarter ended December 31, 2017GAAP net income attributable to Amphastar of $1.9 million, or $0.04 per diluted share, for the fourth quarterAdjusted non-GAAP net income attributable to Amphastar of $6.2 million, or... More